DEALS
Zhong Lun Advises on BIOSTIME’s Refinancing of US$450 Million Loan and Advises on BIOSTIME’s Issuance of US$400 Million Offshore Senior Notes
Zhong Lun Advises on BIOSTIME’s Refinancing of US$450 Million Loan and Advises on BIOSTIME’s Issuance of US$400 Million Offshore Senior Notes
Recently, Biostime Healthy Australia Investment Pty Ltd. (as borrower), a subsidiary of BIOSTIME (HKEx: BIOSTIME), successfully entered into a syndicated facility agreement with Goldman Sachs Australia Pty Ltd. (as arranging bank), The Hong Kong and Shanghai Banking Corporation Ltd. (as agent bank) and the syndicate, with regard to the refinancing of US$450 million for the acquisition of major shares in Swisse Wellness Group Pty Ltd. Certain material onshore subsidiaries of BIOSTIME provided securities and guarantees for the facility. Meanwhile, Biostime International Holdings Ltd., a listed subsidiary of BIOSTIME, successfully issued US$400 million offshore Senior Notes. Goldman Sachs acted as the initial purchaser of this Senior Notes. The Senior Notes were listed and quoted in the Singapore Exchange.
Zhong Lun Law Firm acted as the PRC counsel for BIOSTIME in the aforementioned transactions, and provided comprehensive legal services for the refinancing loan project and offshore Senior Notes issuance project. The legal team was led by Shirley Lu, the partner of Zhong Lun Shanghai Office, and the team members include Joy Gao, Jingbo Zhou, Sophia Chen, Elaine Ye, Rick Cao and Brenda Qiu.
Founded in 1999, BIOSTIME is a provider of high-end pediatric, adult nutrition and care products with established brands home and abroad.
